These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2777430)

  • 1. Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives.
    Nakatsuka M; Kumazawa Y; Matsuura M; Homma JY; Kiso M; Hasegawa A
    Int J Immunopharmacol; 1989; 11(4):349-58. PubMed ID: 2777430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.
    Ikeda S; Matsuura M; Nakatsuka M; Homma JY; Kiso M; Hasegawa A; Nishimura C
    J Clin Lab Immunol; 1990 Aug; 32(4):177-81. PubMed ID: 1966934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
    Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
    Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
    Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
    Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of nonspecific resistance to viral infection by chemically synthesized lipid A-subunit analogs with different backbone structures and acyl groups.
    Ikeda S; Kumazawa Y; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1988 Dec; 10(4-5):167-78. PubMed ID: 2465734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of nonspecific resistance to microbial infections of synthetic lipid A-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone.
    Nakatsuka M; Ikeda S; Kumazawa Y; Matsuura M; Nishimura C; Homma JY; Kiso M; Hasegawa A
    Int J Immunopharmacol; 1990; 12(6):599-603. PubMed ID: 1703131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.
    Ikeda S; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1988; 9(1-2):37-46. PubMed ID: 3389769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
    Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
    Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor and antimicrobial activities of lipid A-subunit analogue GLA-27.
    Nakatsuka M; Kumazawa Y; Ikeda S; Yamamoto A; Nishimura C; Homma JY; Kiso M; Hasegawa A
    J Clin Lab Immunol; 1988 May; 26(1):43-7. PubMed ID: 3184160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of backbone structures and stereospecificities of lipid A-subunit analogues on their biological activities.
    Matsuura M; Kojima Y; Homma JY; Kumazawa Y; Yamamoto A; Kiso M; Hasegawa A
    J Biochem; 1986 May; 99(5):1377-84. PubMed ID: 3486867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stereospecificity of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-40 on the expression of immunopharmacological activities.
    Kumazawa Y; Ikeda S; Takimoto H; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
    Eur J Immunol; 1987 May; 17(5):663-7. PubMed ID: 3495442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological activities of chemically synthesized lipid A-subunit analogue GLA-27 combined with muramyl dipeptide via spacers of different carbon chain length.
    Ikeda S; Kumazawa Y; Sai K; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
    Int J Immunopharmacol; 1988; 10(4):339-46. PubMed ID: 2459075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
    Kumazawa Y; Takimoto H; Yamamoto A; Homma JY; Ogawa Y; Kiso M; Hasegawa A
    FEBS Lett; 1988 Oct; 239(1):117-20. PubMed ID: 3181417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-inducing, pyrogenic and proclotting enzyme of horseshoe crab activation activities of chemically synthesized lipid A analogues.
    Matsuura M; Kojima Y; Homma JY; Kubota Y; Shibukawa N; Shibata M; Inage M; Kusumoto S; Shiba T
    Eur J Biochem; 1983 Dec; 137(3):639-42. PubMed ID: 6600151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of analogs of a lipid A biosynthetic precursor: 1-O-phosphonooxyethyl-4'-O-phosphono-disaccharides with (R)-3-hydroxytetradecanoyl or tetradecanoyl groups at positions 2, 3, 2' and 3'.
    Kusama T; Soga T; Ono Y; Kumazawa E; Shioya E; Osada Y; Kusumoto S; Shiba T
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1994-9. PubMed ID: 1797420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
    Shimizu T; Ohtsuka Y; Yanagihara Y; Itoh H; Nakamoto S; Achiwa K
    Int J Immunopharmacol; 1991; 13(5):605-11. PubMed ID: 1783474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activity.
    Ikeda S; Nishimura C; Matsuura M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1990 Jun; 13(6):327-33. PubMed ID: 1699495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity, mitogenicity, and lethal toxicity of chemically synthesized monosaccharide analogs of lipid A.
    Shimizu T; Masuzawa T; Yanagihara Y; Nakamoto S; Itoh H; Achiwa K
    J Pharmacobiodyn; 1988 Jul; 11(7):512-8. PubMed ID: 3183927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the optically active 4-O-phosphono-D-glucosamine derivatives related to the nonreducing-sugar subunit of bacterial lipid A.
    Kiso M; Tanaka S; Fujita M; Fujishima Y; Ogawa Y; Ishida H; Hasegawa A
    Carbohydr Res; 1987 Apr; 162(1):127-40. PubMed ID: 3594476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective activity of lipid A analogue GLA-60 against murine cytomegalovirus infection in mice.
    Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
    J Med Virol; 1993 Jul; 40(3):222-7. PubMed ID: 8394873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.